Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Nephrostomy devices industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 End-use trends
Chapter 3 Nephrostomy Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevelance of kidney disorders
3.2.1.2 Increased adoption of minimally invasive surgical procedure
3.2.1.3 Technological advancements in nephrostomy devices
3.2.1.4 Increasing awareness among population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Risks associated with the nephrostomy devices
3.2.2.2 Availability of subistitue procedures
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6 Reimbursement scenario
3.7 Pricing analysis, 2022
3.8 Key market trends
3.9 Technology landscape
3.10 Future market trends
3.11 Value chain analysis
3.12 Gap Analysis
3.13 Porter’s analysis
3.14 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis, 2022
4.6 Strategy dashboard, 2022
Chapter 5 Nephrostomy Devices Market Size and Forecast, By Product (USD Million & Units)
5.1 Key trends, by product
5.2 Guidewires
5.3 Drainage Tubes
5.4 Nephrostomy Catheters
5.5 Sheath Dilators
5.6 Others
Chapter 6 Nephrostomy Devices Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Clinics
6.4 Ambulatory Surgical Centers
6.5 Others
Chapter 7 Nephrostomy Devices Market Size and Forecast, By Region (USD Million & Units)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.3.7 Switzerland
7.3.8 The Netherlands
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Thailand
7.4.8 Philippines
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.5.6 Peru
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Israel
7.6.5 Egypt
7.6.6 Turkey
Chapter 8 Company Profiles
8.1 Angiodynamics
8.2 Argon Medical Devices Inc
8.3 B. Braun Melsungen AG
8.4 Becton, Dickinson, and Company
8.5 Boston Scientific Corporation
8.6 Cardinal Health
8.7 Coloplast Group
8.8 Cook Medical
8.9 Envaste Ltd.
8.10 Meditech Devices Pvt. Ltd.
8.11 Olympus Corporation
8.12 ROCAMED
8.13 Teleflex, Inc.
8.14 Uresil LLC.
